CH
抗体药类似物
Research Grade Ociperlimab
All
  • CatalogTD-HS739056
  • ClonalitymAb
  • Application Research Grade Biosimilar
  • SynonymsBGB-A1217,CAS:2342597-93-5
  • Specification
    1mg
  • Prices
    ¥询价
Customized service consulting

Research Grade Ociperlimab


Catalog No. TD-HS739056
Species reactivity Human
Applications Research Grade Biosimilar
Host species Humanized
Isotype IgG1-Kappa
Expression system Mammalian Cells
Clonality Monoclonal
Target VSTM3, TIGIT, V-set and transmembrane domain-containing protein 3, VSIG9, V-set and immunoglobulin domain-containing protein 9, T-cell immunoreceptor with Ig and ITIM domains
Endotoxin level Please contact the lab for this information.
Purity >95% purity as determined by SDS-PAGE.
Purification Protein A/G, purified from cell culture supernatant.
Accession Q495A1
Form Liquid
Storage buffer 0.01M PBS,pH7.4.
Stability and Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C.
Alternate Names BGB-A1217,CAS:2342597-93-5
Background Ociperlimab is a humanized IgG1 anti-TIGIT antibody. Ociperlimab binds to the extracellular domain of human TIGIT with high affinity (KD = 0.135 nM). Ociperlimab blocks the interaction between TIGIT and its ligands PVR or PVR-L2. Ociperlimab can be used in research of cancer.
Note For research use only. Not for use in clinical or therapeutic applications.